Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al.

Anthony Edwin Dear

doi:10.1007/s10557-013-6465-x

Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al.

Anthony Edwin Dear

Eastern Clinical Research Unit

Research output: Contribution to journal › Letter › Other

Original language	English
Pages (from-to)	363 - 364
Number of pages	2
Journal	Cardiovascular Drugs and Therapy
Volume	27
Issue number	5
DOIs	https://doi.org/10.1007/s10557-013-6465-x
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s10557-013-6465-x

Cite this

Dear, A. E. (2013). Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al. Cardiovascular Drugs and Therapy, 27(5), 363 - 364. https://doi.org/10.1007/s10557-013-6465-x

Dear, Anthony Edwin. / Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention : Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al. In: Cardiovascular Drugs and Therapy. 2013 ; Vol. 27, No. 5. pp. 363 - 364.

@article{b5efec9f35cb4c0a82769e4e0221a67d,

title = "Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al.",

author = "Dear, \{Anthony Edwin\}",

year = "2013",

doi = "10.1007/s10557-013-6465-x",

language = "English",

volume = "27",

pages = "363 -- 364",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "5",

}

Dear, AE 2013, 'Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al.', Cardiovascular Drugs and Therapy, vol. 27, no. 5, pp. 363 - 364. https://doi.org/10.1007/s10557-013-6465-x

Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al. / Dear, Anthony Edwin.
In: Cardiovascular Drugs and Therapy, Vol. 27, No. 5, 2013, p. 363 - 364.

Research output: Contribution to journal › Letter › Other

TY - JOUR

T1 - Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention

T2 - Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al.

AU - Dear, Anthony Edwin

PY - 2013

Y1 - 2013

UR - http://link.springer.com.ezproxy.lib.monash.edu.au/article/10.1007%2Fs10557-013-6465-x

U2 - 10.1007/s10557-013-6465-x

DO - 10.1007/s10557-013-6465-x

M3 - Letter

SN - 0920-3206

VL - 27

SP - 363

EP - 364

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 5

ER -

Dear AE. Incretin based therapeutics: Connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: “Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa b activation” by Dai et al. Cardiovascular Drugs and Therapy. 2013;27(5):363 - 364. doi: 10.1007/s10557-013-6465-x

UN SDGs

Access to Document

Other files and links

Cite this